BioHarvest Sciences Balance Sheet Health
Financial Health criteria checks 3/6
BioHarvest Sciences has a total shareholder equity of $6.7M and total debt of $1.2M, which brings its debt-to-equity ratio to 17.4%. Its total assets and total liabilities are $27.0M and $20.3M respectively.
Key information
17.4%
Debt to equity ratio
US$1.16m
Debt
| Interest coverage ratio | n/a |
| Cash | US$5.17m |
| Equity | US$6.70m |
| Total liabilities | US$20.31m |
| Total assets | US$27.01m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BHST's short term assets ($9.3M) exceed its short term liabilities ($8.9M).
Long Term Liabilities: BHST's short term assets ($9.3M) do not cover its long term liabilities ($11.4M).
Debt to Equity History and Analysis
Debt Level: BHST has more cash than its total debt.
Reducing Debt: BHST had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BHST has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: BHST has less than a year of cash runway if free cash flow continues to reduce at historical rates of 26.6% each year